Placement of an intracranial pressure (ICP) monitor is a surgical procedure performed by a healthcare prescriber (physician, or nurse practitioner or physician assistant depending on state scope of practice regulations) and the removal of such a device is the responsibility of the healthcare prescriber. Informed consent to complete the procedure must be obtained (see Chapter 51).
The registered nurse (RN) is responsible for monitoring the child and system; monitoring takes place in an intensive care setting.
Sedation and pain management of the child with ICP monitoring are implemented on an individual basis according to the child’s diagnosis and unique healthcare needs.
The accuracy of the monitoring system is assessed at least once a shift by zero-balancing the ICP system, checking the status of system alarms, and frequently assessing the level of the transducer and device placement.
Surgical examination light (if needed by healthcare prescriber)
Shaving device (electric razor with disposable blades or several disposable razors)
Sterile antiseptic prep swabs (e.g., povidone-iodine, chlorhexidine)
Sterile gowns, gloves, masks, and caps
Sterile drapes or towels
Lidocaine (xylocaine) local anesthetic (0.5% or 1%)
Sterile syringes (assortment of sizes: 3 and 5 mL, and tuberculin)
Needles (22- and 25-gauge)
Cranial drill and bit
Alcohol antiseptic
Scalpel
Sterile retractor
Forceps
Sterile scissors
Hemostats
Subarachnoid bolt, Silastic intraventricular catheter, or intraparenchymal catheter (institutional preference)
Suture material (usually 2-0 to 3-0 nylon/silk)
Gauze dressing
Sterile transparent dressing (if needed)
Gauze dressing roll (3-in)
Tape (1-in)
Preservative-free sterile normal saline for injection
Individual institution monitoring system and equipment (i.e., ICP module, monitor, transducer, cable, and hookup)
Level to check height of transducer
Sedation and pain medications (as ordered)
Antibiotics (as ordered)
Assess the child’s and the family’s cognitive level, readiness, and ability to process information.
Perform detailed baseline and ongoing neurologic assessments. Assess child for signs and symptoms of increased ICP, including altered or decreased level of consciousness, anxiety, restlessness, irritability, agitation, lethargy, confusion, drowsiness, headaches, seizures, posturing, inappropriate motor function or dysfunction, widened pulse pressure, bradycardia, altered respiratory pattern, and pupillary dysfunction. An infant may also display tense or bulging fontanels, separated cranial sutures, increased head circumference, projectile vomiting, highpitched “neuro” cry, or paralysis of upward gaze of the eyes (“sun-setting sign”).
Ensure that informed consent has been obtained and that the appropriate documents are signed and present in the child’s medical record. If the procedure is urgent, ensure that two physicians have signed the consent.
Reinforce the need for device placement, as appropriate, to both the child and the family.
Reinforce the healthcare prescriber’s explanation of the risks and benefits of monitoring.
Discuss with family the need to talk to the child and provide physical comfort, even while the child is sedated.
Setup for Bedside Insertion of ICP Monitoring by Healthcare Prescriber
|